What are the benefits and harms for chlamydia screening in asymptomatic men and women?
Metadata[+] Show full item record
Annual Chlamydia trachomatis screening in high-risk asymptomatic, nonpregnant women reduces the incidence of pelvic inflammatory disease (PID) (SOR: B, systematic review and inconsistent RCTs). Evidence is insufficient to suggest benefit from routine screening of asymptomatic males. Harms appear to be minimal.
Evidence-based practice 15, no. 10 (2012): 08-09